Regeneron Pharmaceuticals, Inc.

Legal & General Group Plc REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/9/2026

Shares

743,027

Value ($000)

573,520

Weight

0.1%

2013 Q4 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/9/2026	573,520	0.1%	743,027	12/31/2025
2025 Q3	11/13/2025	433,150	0.1%	770,359	9/30/2025
2025 Q2	8/12/2025	388,280	0.1%	739,581	6/30/2025
2025 Q1	5/15/2025	473,791	0.1%	747,033	3/31/2025
2024 Q4	2/13/2025	553,820	0.1%	777,477	12/31/2024
2024 Q3	2/28/2025	825,326	0.2%	785,094	9/30/2024
2024 Q2	5/29/2025	823,792	0.2%	783,793	6/30/2024
2024 Q1	5/29/2025	788,549	0.2%	819,282	3/31/2024
2023 Q4	5/29/2025	726,072	0.2%	826,688	12/31/2023
2023 Q3	11/14/2023	674,998	0.2%	820,208	9/30/2023
2023 Q2	8/14/2023	608,697	0.2%	847,129	6/30/2023
2023 Q1	5/15/2023	697,701	0.2%	849,127	3/31/2023
2022 Q4	2/14/2023	599,824	0.2%	831,369	12/31/2022
2022 Q3	11/14/2022	601,374	0.2%	872,985	9/30/2022
2022 Q2	8/22/2022	522,138	0.2%	883,287	6/30/2022
2022 Q1	5/16/2022	564,250	0.2%	807,896	3/31/2022
2021 Q4	2/14/2022	473,963	0.1%	750,509	12/31/2021
2021 Q3	11/15/2021	463,637	0.2%	766,118	9/30/2021
2021 Q2	8/12/2021	416,142	0.1%	745,052	6/30/2021
2021 Q1	5/17/2021	335,288	0.1%	708,644	3/31/2021
2020 Q4	2/12/2021	349,397	0.1%	723,226	12/31/2020
2020 Q3	11/13/2020	382,467	0.2%	683,247	9/30/2020
2020 Q2	8/14/2020	431,815	0.2%	692,428	6/30/2020
2020 Q1	5/14/2020	260,584	0.2%	534,499	3/31/2020
2019 Q4	2/13/2020	196,103	0.1%	522,294	12/31/2019
2014 Q1	5/14/2014	95,612	0.1%	318,410	3/31/2014
2013 Q4	2/7/2014	86,342	0.1%	313,697	12/31/2013